Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Accelerating Initiation of Adequate Antimicrobial Therapy Using Real-Time Decision Support and Microarray Testing.

Tchou MJ, Andersen H, Robinette E, Mortensen JE, Powell EA, Ankrum A, Washam MC, Haslam DB, Courter JD.

Pediatr Qual Saf. 2019 Aug 5;4(4):e191. doi: 10.1097/pq9.0000000000000191. eCollection 2019 Jul-Aug.

2.

Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.

Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, Harger NJ, Foertsch MJ, Winter JB, Carter KE, Van Fleet SL, Athota K, Mueller EW.

Pharmacotherapy. 2019 Nov;39(11):1066-1076. doi: 10.1002/phar.2332. Epub 2019 Oct 22.

PMID:
31549737
3.

Improving the Transition of Intravenous to Enteral Antibiotics in Pediatric Patients with Pneumonia or Skin and Soft Tissue Infections.

Girdwood SCT, Sellas MN, Courter JD, Liberio B, Tchou MJ, Herrmann LE, Dewan ML, Statile AM, Unaka NI.

J Hosp Med. 2020 Jan 1;15(1):10-15. doi: 10.12788/jhm.3253. Epub 2019 Jul 24.

PMID:
31339843
4.

Route of administration for antibiotics with high oral bioavailability.

Smith MJ, Thurm C, Shah SS, Patel SJ, Kronman MP, Gerber JS, Courter JD, Lee BR, Newland JG, Hersh AL.

Infect Control Hosp Epidemiol. 2018 Dec 27:1-2. doi: 10.1017/ice.2018.329. [Epub ahead of print] No abstract available.

PMID:
30587255
5.

Reliability of the Verigene system for the identification for Gram-positive Bacteria and detection of antimicrobial resistance markers from children with bacteremia.

Beckman M, Washam MC, DeBurger B, Haslam DB, Courter JD, Andersen H, Schaffzin JK, Tchou MJ, Ankrum A, Mortensen J.

Diagn Microbiol Infect Dis. 2019 Mar;93(3):191-195. doi: 10.1016/j.diagmicrobio.2018.10.005. Epub 2018 Oct 14.

PMID:
30477953
6.

Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016.

Spaulding AB, Thurm C, Courter JD, Banerjee R, Gerber JS, Newland JG, Parker SK, Brogan TV, Kronman MP, Shah SS, Smith MJ, Patel SJ, Lee BR, Hersh AL.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1487-1490. doi: 10.1017/ice.2018.259. Epub 2018 Oct 29.

PMID:
30370879
7.

Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related Diabetes.

Smego A, Lawson S, Courter JD, Warden D, Corathers S.

Hosp Pediatr. 2018 May;8(5):288-292. doi: 10.1542/hpeds.2017-0199.

8.

Variability in Antibiotic Use Across PICUs.

Brogan TV, Thurm C, Hersh AL, Gerber JS, Smith MJ, Shah SS, Courter JD, Patel SJ, Parker SK, Kronman MP, Lee BR, Newland JG.

Pediatr Crit Care Med. 2018 Jun;19(6):519-527. doi: 10.1097/PCC.0000000000001535.

PMID:
29533352
9.

Trends in Intravenous Antibiotic Duration for Urinary Tract Infections in Young Infants.

Lewis-de Los Angeles WW, Thurm C, Hersh AL, Shah SS, Smith MJ, Gerber JS, Parker SK, Newland JG, Kronman MP, Lee BR, Brogan TV, Courter JD, Spaulding A, Patel SJ.

Pediatrics. 2017 Dec;140(6). pii: e20171021. doi: 10.1542/peds.2017-1021. Epub 2017 Nov 2.

10.

Accuracy of Administrative Data for Antimicrobial Administration in Hospitalized Children.

Courter JD, Parker SK, Thurm C, Kronman MP, Weissman SJ, Shah SS, Hersh AL, Brogan TV, Patel SJ, Smith MJ, Lee BR, Newland JG, Gerber JS.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):261-263. doi: 10.1093/jpids/pix064.

PMID:
28992185
11.

Automated identification of antibiotic overdoses and adverse drug events via analysis of prescribing alerts and medication administration records.

Kirkendall ES, Kouril M, Dexheimer JW, Courter JD, Hagedorn P, Szczesniak R, Li D, Damania R, Minich T, Spooner SA.

J Am Med Inform Assoc. 2017 Mar 1;24(2):295-302. doi: 10.1093/jamia/ocw086.

12.

Pharmacodynamically Guided Levofloxacin Dosing for Pediatric Community-Acquired Pneumonia.

Courter JD, Nichols KR, Kazazian C, Girotto JE.

J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):118-122. doi: 10.1093/jpids/piw006.

PMID:
26903555
13.

Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1-Erratum.

Scott JR, Courter JD, Saldaña SN, Widemann BC, Fisher M, Weiss B, Perentesis J, Vinks AA.

Ther Drug Monit. 2016 Apr;38(2):284. Epub 2016 Jan 21. No abstract available.

14.

Decreasing Duration of Antibiotic Prescribing for Uncomplicated Skin and Soft Tissue Infections.

Schuler CL, Courter JD, Conneely SE, Frost MA, Sherenian MG, Shah SS, Gosdin CH.

Pediatrics. 2016 Feb;137(2):e20151223. doi: 10.1542/peds.2015-1223. Epub 2016 Jan 18.

15.

Antimicrobial stewardship programs in freestanding children's hospitals.

Hersh AL, De Lurgio SA, Thurm C, Lee BR, Weissman SJ, Courter JD, Brogan TV, Shah SS, Kronman MP, Gerber JS, Newland JG.

Pediatrics. 2015 Jan;135(1):33-9. doi: 10.1542/peds.2014-2579. Epub 2014 Dec 8.

PMID:
25489018
16.

Hospital outcomes associated with guideline-recommended antibiotic therapy for pediatric pneumonia.

Thomson J, Ambroggio L, Murtagh Kurowski E, Statile A, Graham C, Courter JD, Sheehan B, Iyer S, White CM, Shah SS.

J Hosp Med. 2015 Jan;10(1):13-8. doi: 10.1002/jhm.2265. Epub 2014 Sep 27.

17.

Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics.

Downes KJ, Hahn A, Wiles J, Courter JD, Vinks AA.

Int J Antimicrob Agents. 2014 Mar;43(3):223-30. doi: 10.1016/j.ijantimicag.2013.11.006. Epub 2013 Dec 17. Review.

18.

Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Stockmann C, Spigarelli MG, Campbell SC, Constance JE, Courter JD, Thorell EA, Olson J, Sherwin CM.

Paediatr Drugs. 2014 Feb;16(1):67-81. doi: 10.1007/s40272-013-0057-x. Review.

PMID:
24218112
19.

Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1.

Scott JR, Courter JD, Saldaña SN, Widemann BC, Fisher M, Weiss B, Perentesis J, Vinks AA.

Ther Drug Monit. 2013 Jun;35(3):332-7. doi: 10.1097/FTD.0b013e318286dd3f. Erratum in: Ther Drug Monit. 2016 Jan 21;38(2):284.

20.

Role of tipranavir in treatment of patients with multidrug-resistant HIV.

Courter JD, Teevan CJ, Li MH, Girotto JE, Salazar JC.

Ther Clin Risk Manag. 2010 Oct 5;6:431-41. doi: 10.2147/TCRM.S4207.

21.

Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis.

Courter JD, Baker WL, Nowak KS, Smogowicz LA, Desjardins LL, Coleman CI, Girotto JE.

Ann Pharmacother. 2010 Mar;44(3):471-8. doi: 10.1345/aph.1M344. Epub 2010 Feb 11.

PMID:
20150506
22.

Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric population.

Courter JD, Kuti JL, Girotto JE, Nicolau DP.

Pediatr Blood Cancer. 2009 Sep;53(3):379-85. doi: 10.1002/pbc.22051.

PMID:
19422028
23.

Tipranavir: a new protease inhibitor for the pediatric population.

Courter JD, Girotto JE, Salazar JC.

Expert Rev Anti Infect Ther. 2008 Dec;6(6):797-803. doi: 10.1586/14787210.6.6.797. Review.

PMID:
19053893

Supplemental Content

Loading ...
Support Center